Lucas Montarce is recorded as CFO at ELI LILLY & Co (LLY). ELI LILLY & Co reported in an 8-K filed September 9, 2024 that Lucas Montarce was appointed executive vice president and chief financial officer, effective September 9, 2024. The proxy statement of ELI LILLY & Co reports total compensation of $8,483,315 for Lucas Montarce in fiscal 2025, including a base salary of $1,000,000. Disclosed compensation is on record for 2 fiscal years. Lucas Montarce has spoken on 6 earnings calls across 1 company, most recently for ELI LILLY & Co on August 5, 2026. ELI LILLY & Co is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at ELI LILLY & Co includes Juan Luciano (CEO), David Ricks (Chairman and Board Member), Kimberly Johnson (COO) and 6 others.
“the Board of Directors of the Company elected Lucas Montarce, age 47, as executive vice president and chief financial officer of the Company following an internal and external search performed across industries.”
ELI LILLY & Co Form 8-K, filed September 9, 2024
· Read the filing
Lucas Montarce on recent calls
“As shown on slide 7, Q2 was another strong quarter of financial performance. Revenue grew 48% compared to Q2 2025, driven by Zepan and Moncharo, with strong momentum across all specific areas and geographies.”
“As shown on slide 6, Q1 was another strong quarter of financial performance. Revenue grew 56% compared to Q1 2025, driven by Zeman and Monjaro, and solid momentum across all therapeutic areas and geographies.”
“We deliver robust financial performance in 2025. Our full-year revenue of $65.2 billion increased by 45% compared to 2024, and earnings per share grew by 86% to $24.21.”
“As shown on Slide 7, Q3 was another strong quarter of financial performance. Revenue grew 54% compared to Q3 2024, driven by our key products. Gross margin as a percentage of revenue was 83.6% in Q3, an increase of 1.4 percentage points versus the same quarter last year.”
“As shown on Slide 7, Q1 was another strong quarter of financial performance with revenue growing 45% compared to Q1 2024, driven by our key products. Gross margin as a percentage of revenue was 83.5% in Q1, an increase of 1 percentage point versus the same quarter last year.”
